gms | German Medical Science

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2018)

23.10. - 26.10.2018, Berlin

Long-term follow-up of revision osteochondral allograft transplantation of the ankle

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Florian Gaul - Shiley Center for Orthopaedic Research and Education, Scripps Health, La Jolla, United States
  • Luis Eduardo Tirico - University of São Paulo, Hospital das Clinicas, Medical School, São Paulo, Brazil
  • Julie McCauley - Shiley Center for Orthopaedic Research and Education, Scripps Health, La Jolla, United States
  • William Bugbee - Shiley Center for Orthopaedic Research and Education, Scripps Health, La Jolla, United States

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2018). Berlin, 23.-26.10.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocPT28-18

doi: 10.3205/18dkou826, urn:nbn:de:0183-18dkou8262

Veröffentlicht: 6. November 2018

© 2018 Gaul et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objectives: Osteochondral allograft (OCA) transplantation is a useful alternative for treatment of posttraumatic ankle arthritis in young patients but has a relatively high failure rate and further procedures are often required. The purpose of this study was to evaluate outcomes of patients who underwent revision OCA transplantation of the ankle after failed primary OCA transplantation.

Methods: Twenty patients underwent revision OCA transplantation of the ankle between 1988 and 2015. Mean age was 44 years, 55% were female. The mean time from primary to revision OCA was 3.0 ± 1.7 years. All patients had a minimum follow-up of 2 years. Outcomes included the AAOS Foot and Ankle Module (AAOS-FAM) and questionnaires evaluating pain and satisfaction. Failure of the revision OCA was defined as a conversion to arthroplasty, arthrodesis, or amputation.

Results: Ten of 20 ankles required further surgery, of which 30% were considered OCA revision failures (4 arthrodeses, 1 arthroplasty, and 1 amputation). The mean time to failure was 6.7 (range, 0.6-13.1) years. Survivorship of the revision OCA was 84% at 5 years and 65% at 10 years. The 14 patients with grafts remaining in situ had an average follow-up of 10.3 years; mean AAOS-FAM Core Score was 70.5 (range, 42.3-99). Of the patients that answered the follow-up questions, 4 of 7 reported moderate to severe pain, and 5 of 12 were satisfied with the results after the procedure.

Conclusion: Although the results of revision ankle OCA transplantation are not inferior to primary OCA transplantation, the high rates of persistent pain, further surgery, and graft failure suggest that the indications for OCA as a revision procedure should be carefully evaluated, with proper patient selection. Considering the treatment alternatives, revising a failed OCA transplantation is a useful treatment option, especially for young and active patients who wish to avoid arthrodesis or arthroplasty.